Nephros Inc (NEPH) stock
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3028% below fair value
$3.31+0.24 (+7.82%)
Close on Nov 12, 2026Market cap $35.95MP/E 18.4Yield –
Nephros ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Nephros's ebitda for the twelve months ending Sep 30, 2026 was $1.95M, up 22.7% year over year. For fiscal 2025 it was $1.29M, up 812.1% from the year before. The highest annual figure on record is $1.29M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.29M | +812.1% |
| FY2024 | Dec 31, 2024 | $141.00K | – |
| FY2023 | Dec 31, 2023 | -$1.38M | – |
| FY2022 | Dec 31, 2022 | -$4.12M | – |
| FY2021 | Dec 31, 2021 | -$3.06M | – |
| FY2020 | Dec 31, 2020 | -$4.08M | – |
| FY2019 | Dec 31, 2019 | -$2.97M | – |
| FY2018 | Dec 31, 2018 | -$2.85M | – |
| FY2017 | Dec 31, 2017 | -$2.01M | – |
| FY2016 | Dec 31, 2016 | -$2.64M | – |
| FY2015 | Dec 31, 2015 | -$3.42M | – |
| FY2014 | Dec 31, 2014 | -$2.66M | – |
| FY2013 | Dec 31, 2013 | -$3.31M | – |
| FY2012 | Dec 31, 2012 | -$3.32M | – |
| FY2011 | Dec 31, 2011 | -$2.22M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $530.00K | +52.3% |
| Q2 FY2026 | Jun 30, 2026 | $1.24M | +338.9% |
| Q1 FY2026 | Mar 31, 2026 | $126.00K | -79.2% |
| Q4 FY2025 | Dec 31, 2025 | $50.00K | -85.8% |
| Q3 FY2025 | Sep 30, 2025 | $348.00K | +45.0% |
| Q2 FY2025 | Jun 30, 2025 | $283.00K | – |
| Q1 FY2025 | Mar 31, 2025 | $605.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $351.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $240.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$283.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$167.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$598.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$148.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$381.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$252.00K | – |
| Q4 FY2022 | Dec 31, 2022 | -$637.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.23M | – |
| Q2 FY2022 | Jun 30, 2022 | -$763.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.50M | – |
| Q4 FY2021 | Dec 31, 2021 | -$679.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$753.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.07M | – |
| Q1 FY2021 | Mar 31, 2021 | -$968.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$669.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$883.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.55M | – |
| Q1 FY2020 | Mar 31, 2020 | -$980.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$247.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$651.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$820.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.25M | – |
| Q4 FY2018 | Dec 31, 2018 | -$689.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$469.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$613.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.08M | – |
| Q4 FY2017 | Dec 31, 2017 | -$363.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$458.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$640.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$546.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$550.00K | – |
See a number that looks wrong?